Innovative approaches to improve outcomes in transplantation

被引：24

作者：

Shapiro, Ron ^{[1
]}

机构：

[1] UPMC Montefiore 7S, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA

来源：

NATURE REVIEWS NEPHROLOGY | 2011年 / 7卷 / 02期

关键词：

D O I：

10.1038/nrneph.2010.179

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

renal transplantation offers the potential for improved quality and length of life to patients with end-stage renal disease; however, graft rejection and immunosuppression-related toxicities can hamper the effectiveness of this therapy. seminal publications from 2010 have addressed these obstacles, and provide insight into new and innovative approaches to improve outcomes in renal transplant recipients.

引用

页码：68 / 70

页数：3

共 10 条

[1] A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study) [J].

Durrbach, A. ;

Pestana, J. M. ;

Pearson, T. ;

Vincenti, F. ;

Garcia, V. D. ;

Campistol, J. ;

del Carmen Rial, M. ;

Florman, S. ;

Block, A. ;

Di Russo, G. ;

Xing, J. ;

Garg, P. ;

Grinyo, J. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) :547-557

[2]

POOMMIPANIT N, 2010, TRANSPLANTATION, V89, P277

[3]

ROBBINS WR, 2010, AM J TRANSPLANT S4, V10, P84

[4]

ROBBINS WR, 2010, AM J TRANSPLANT S4, V10, P85

[5]

ROBBINS WR, 2010, AM J TRANSPLANT, V10, P84

[6] Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial [J].

Salgo, R. ;

Gossmann, J. ;

Schoefer, H. ;

Kachel, H. G. ;

Kuck, J. ;

Geiger, H. ;

Kaufmann, R. ;

Scheuermann, E. H. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (06) :1385-1393

[7] Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies [J].

Sberro-Soussan, R. ;

Zuber, J. ;

Suberbielle-Boissel, C. ;

Candon, S. ;

Martinez, F. ;

Snanoudj, R. ;

Rabant, M. ;

Pallet, N. ;

Nochy, D. ;

Anglicheau, D. ;

Leruez, M. ;

Loupy, A. ;

Thervet, E. ;

Hermine, O. ;

Legendre, C. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) :681-686

[8]

Stegall MD, 2010, AM J TRANSPLANT, V10, P39

[9] A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) [J].

Vincenti, F. ;

Charpentier, B. ;

Vanrenterghem, Y. ;

Rostaing, L. ;

Bresnahan, B. ;

Darji, P. ;

Massari, P. ;

Mondragon-Ramirez, G. A. ;

Agarwal, M. ;

Di Russo, G. ;

Lin, C. -S. ;

Garg, P. ;

Larsen, C. P. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) :535-546

[10] Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection [J].

Walsh, R. Carlin ;

Everly, Jason J. ;

Brailey, Paul ;

Rike, Adele H. ;

Arend, Lois J. ;

Mogilishetty, Gautham ;

Govil, Amit ;

Roy-Chaudhury, Prabir ;

Alloway, Rita R. ;

Woodle, E. Steve .

TRANSPLANTATION, 2010, 89 (03) :277-284

← 1 →